Comments
The shares of Dr Reddy's Laboratories gained 1.30 per cent to Rs 3,902 on Thursday. Earlier, the company had announced receiving approval nod from the US Food and Drug Administration for Elyxyb (celecoxib oral solution). The drug is used for the treatment of acute migraine.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.